» Articles » PMID: 37620809

Severe Falciparum Malaria in Pregnancy in Southeast Asia: a Multi-centre Retrospective Cohort Study

Abstract

Background: Severe malaria in pregnancy causes maternal mortality, morbidity, and adverse foetal outcomes. The factors contributing to adverse maternal and foetal outcomes are not well defined. We aimed to identify the factors predicting higher maternal mortality and to describe the foetal mortality and morbidity associated with severe falciparum malaria in pregnancy.

Methods: A retrospective cohort study was conducted of severe falciparum malaria in pregnancy, as defined by the World Health Organization severe malaria criteria. The patients were managed prospectively by the Shoklo Malaria Research Unit (SMRU) on the Thailand-Myanmar border or were included in hospital-based clinical trials in six Southeast Asian countries. Fixed-effects multivariable penalised logistic regression was used for analysing maternal mortality.

Results: We included 213 (123 SMRU and 90 hospital-based) episodes of severe falciparum malaria in pregnancy managed between 1980 and 2020. The mean maternal age was 25.7 (SD 6.8) years, and the mean gestational age was 25.6 (SD 8.9) weeks. The overall maternal mortality was 12.2% (26/213). Coma (adjusted odds ratio [aOR], 7.18, 95% CI 2.01-25.57, p = 0.0002), hypotension (aOR 11.21, 95%CI 1.27-98.92, p = 0.03) and respiratory failure (aOR 4.98, 95%CI 1.13-22.01, p = 0.03) were associated with maternal mortality. Pregnant women with one or more of these three criteria had a mortality of 29.1% (25/86) (95%CI 19.5 to 38.7%) whereas there were no deaths in 88 pregnant women with hyperparasitaemia (> 10% parasitised erythrocytes) only or severe anaemia (haematocrit < 20%) only. In the SMRU prospective cohort, in which the pregnant women were followed up until delivery, the risks of foetal loss (23.3% by Kaplan-Meier estimator, 25/117) and small-for-gestational-age (38.3%, 23/60) after severe malaria were high. Maternal death, foetal loss and preterm birth occurred commonly within a week of diagnosis of severe malaria.

Conclusions: Vital organ dysfunction in pregnant women with severe malaria was associated with a very high maternal and foetal mortality whereas severe anaemia or hyperparasitaemia alone were not associated with poor prognosis, which may explain the variation of reported mortality from severe malaria in pregnancy. Access to antenatal care must be promoted to reduce barriers to early diagnosis and treatment of both malaria and anaemia.

Citing Articles

Exchange transfusion combined with artesunate (ET-AS) as a safe and effective therapy in severe P. falciparum malaria: a case series.

Zhang J, Chen L, Zhang M, Yao M, Ren S, Liu H BMC Infect Dis. 2024; 24(1):603.

PMID: 38898395 PMC: 11186206. DOI: 10.1186/s12879-024-09381-2.

References
1.
Lon C, Timmermans A, Buathong N, Nou S, Se Y, Sitthy N . Severe malaria in Battambang Referral Hospital, an area of multidrug resistance in Western-Cambodia: a retrospective analysis of cases from 2006-2009. Malar J. 2013; 12:217. PMC: 3699359. DOI: 10.1186/1475-2875-12-217. View

2.
Day N, Nguyen H, Nguyen T, Tran T, Pham P, Dinh X . A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med. 1996; 335(2):76-83. DOI: 10.1056/NEJM199607113350202. View

3.
Singh N, Shukla M, Valecha N . Malaria parasite density in pregnant women of district Jabalpur, Madhya Pradesh. Indian J Malariol. 1996; 33(1):41-7. View

4.
Chandrasiri U, Randall L, Saad A, Bashir A, Rogerson S, Adam I . Low antibody levels to pregnancy-specific malaria antigens and heightened cytokine responses associated with severe malaria in pregnancy. J Infect Dis. 2013; 209(9):1408-17. DOI: 10.1093/infdis/jit646. View

5.
Nyaga V, Arbyn M, Aerts M . Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health. 2015; 72(1):39. PMC: 4373114. DOI: 10.1186/2049-3258-72-39. View